Details
Title
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?
Author
Zeidan, Amer M 1 ; Stahl, Maximilian 1 ; DeVeaux, Michelle 2 ; Smith, Giri 1 ; Huntington, Scott 1 ; Podoltsev, Nikolai 1
; Wang, Rong 3 ; Ma, Xiaomei 3 ; Davidoff, Amy J 4 ; Gore, Steven D 1
1 Yale University and Yale Cancer Center, New Haven, CT, USA; Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA
2 Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
3 Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA; Department of Chronic Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA
4 Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA; Department of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA
; Wang, Rong 3 ; Ma, Xiaomei 3 ; Davidoff, Amy J 4 ; Gore, Steven D 1 1 Yale University and Yale Cancer Center, New Haven, CT, USA; Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA
2 Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
3 Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA; Department of Chronic Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA
4 Yale Cancer Outcomes Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT, USA; Department of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA
Pages
1-4
Publication year
2018
Publication date
Jun 2018
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2053309105
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.